CVS Health
CVS
CVS Health (CVS) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Argus Research | Maintained | Buy | $114.00 from $104.00 | Aug 19, 2026 |
| JP Morgan | Maintained | Overweight | $118.00 from $111.00 | Aug 12, 2026 |
| Barclays | Maintained | Overweight | $108.00 from $106.00 | Aug 6, 2026 |
| Evercore ISI Group | Maintained | Outperform | $125.00 from $130.00 | Aug 6, 2026 |
| UBS | Maintained | Buy | $126.00 from $122.00 | Aug 6, 2026 |
| UBS | Maintained | Buy | $122.00 from $115.00 | Jul 24, 2026 |
| Truist Securities | Maintained | Buy | $118.00 from $108.00 | Jul 14, 2026 |
| Wells Fargo | Maintained | Overweight | $123.00 from $103.00 | Jul 13, 2026 |
| RBC Capital | Maintained | Outperform | $113.00 from $107.00 | Jul 9, 2026 |
| Cantor Fitzgerald | Maintained | Overweight | $110.00 from $100.00 | Jul 7, 2026 |
| B of A Securities | Maintained | Buy | $110.00 from $100.00 | Jun 23, 2026 |
| Mizuho | Maintained | Outperform | $115.00 from $110.00 | Jun 8, 2026 |
| Morgan Stanley | Maintained | Overweight | $111.00 from $106.00 | Jun 4, 2026 |
| Truist Securities | Maintained | Buy | $108.00 from $102.00 | Jun 1, 2026 |
| Barclays | Maintained | Overweight | $106.00 from $101.00 | May 26, 2026 |
| Mizuho | Maintained | Outperform | $110.00 from $102.00 | May 20, 2026 |
| Morgan Stanley | Maintained | Overweight | $106.00 from $93.00 | May 14, 2026 |
| Bernstein | Maintained | Outperform | $106.00 from $94.00 | May 13, 2026 |
| JP Morgan | Maintained | Overweight | $111.00 from $101.00 | May 12, 2026 |
| TD Cowen | Maintained | Buy | $110.00 from $105.00 | May 11, 2026 |
Frequently asked questions
What is the latest analyst rating on CVS?
On Aug 19, 2026, Argus Research maintained CVS Health at Buy with a price target of $114.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.